Patents
Patents for C07B 59 - Introduction of isotopes of elements into organic compounds (2,678)
03/2004
03/17/2004EP1397370A1 B-benzyloxyaspartate derivatives with amino group on benzene ring
03/17/2004EP1397327A2 DEUTERATED N-SUBSTITUTED AND $g(a)-SUBSTITUTED DIPHENYLALKOXY ACETIC ACID AMINO ALKYL ESTERS AND MEDICAMENTS CONTAINING THESE COMPOUNDS
03/11/2004WO2002102743A9 DEUTERATED N-SUBSTITUTED AND α-SUBSTITUTED DIPHENYLALKOXY ACETIC ACID AMINO ALKYL ESTERS AND MEDICAMENTS CONTAINING THESE COMPOUNDS
03/09/2004CA2216423C Ternary radiopharmaceutical complexes
03/04/2004US20040043920 Chelate compound of metal and dithiocarbamate; therapy, diagnosis
02/2004
02/24/2004US6696551 225Ac-HEHA and related compounds, methods of synthesis and methods of use
02/19/2004WO2003065882A3 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts
02/19/2004US20040033197 Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts
02/19/2004US20040033196 Synthesis of 17F labeled fluoroalkanes
02/12/2004US20040029963 Use of pamoic acid or one of its derivatives, or one of its analogues , for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
02/05/2004WO2004010846A2 Design and synthesis of renal dipeptidase inhibitors
02/05/2004US20040024307 Para-hydrogen labeled agents and their use in magnetic resonance imaging
02/05/2004CA2493773A1 A method of deuteration of an aromatic ring
02/04/2004EP0863858B1 Mass-based encoding and qualitative analysis of combinatorial libraries
02/04/2004CN1473158A Radiopharmaceuticals for diagnosing alzheimer's disease
01/2004
01/28/2004EP1383752A2 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
01/21/2004EP1381396A2 Tc and re labeled radioactive glycosylated octreotide derivatives
01/13/2004US6676926 Radiopharmaceuticals for diagnosing Alzheimer's disease
12/2003
12/31/2003WO2003078358A3 Use of microfabricated devices for radiosynthesis
12/30/2003CA2001765C Chelants possessing ortho ligating functionality and complexes thereof
12/18/2003WO2003104430A2 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes
12/18/2003WO2003104166A1 Process for deuteration of inert methylene
12/18/2003CA2488773A1 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes
12/09/2003US6660246 Ligands and metal complexes thereof
12/04/2003WO2003099746A1 Method for the production of 18f-fluorinated alpha acids
11/2003
11/27/2003US20030220234 A cyclosporine A derivative with isotopic or chemical substitution in the amino acid position selected from the group consisting of 1,3, and 9 or combination
11/26/2003EP1363954A2 Polymer precursors of radiolabeled compounds, and methods of making and using the same
11/26/2003EP0974572B1 Novel process for producing alcohols
11/06/2003WO2003064678A3 Apparatus for synthesis of radiolabeled compounds
11/05/2003EP1359147A1 4,4-disubstituted-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and processes for making the same
11/04/2003CA2123570C Cocaine receptor binding ligands
10/2003
10/30/2003WO2003089438A1 Labeled oxazinocarbazoles as diagnostic agents
10/21/2003CA2093896C Hormone labelling with rhenium and technetium
10/16/2003US20030194748 Method for labeling with tritium
10/15/2003EP1351930A2 Protease inhibitors
10/15/2003CN1449375A Use of pamoic acid or one of derivatives or analogs thereof for preparing a medicament used for treating diseases
10/08/2003EP0533845B1 USING 5,10,15,20-TETRAKIS(r-CARBOXYPHENYL)PORPHINE FOR DETECTING AND TREATING LUNG CANCER
10/02/2003WO2003080544A1 Radiofluorination methods
10/01/2003EP1066235B1 Synthetic endogenous cannabinoid analogues and uses thereof
09/2003
09/25/2003WO2003078358A2 Use of microfabricated devices for radiosynthesis
09/17/2003CN1121374C Novel trienoic retinoid compounds and method
09/12/2003WO2002085418A3 Tc and re labeler radioactive glycosylated octreotide derivatives
09/10/2003EP1341795A2 Novel labeled resiniferatoxin derivatives
09/04/2003US20030166144 Growth hormone secretagogue receptor family
09/03/2003EP0929533B1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same
09/02/2003US6613739 Immunosuppressants
08/2003
08/27/2003EP1337532A2 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit
08/27/2003EP0760685B1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
08/19/2003US6607710 Provide a bisphosphonic acid derivative and said bisphosphonic acid derivative being labeled with a radioactive nuclide, which has properties of rapid accumulation to the bone and rapid urinary excretion.
08/14/2003WO2003065882A2 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts
08/14/2003WO2002070020A9 Polymer precursors of radiolabeled compounds, and methods of making and using the same
08/14/2003CA2474142A1 Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts
08/12/2003US6605593 Enhanced efficacy and reduced toxicity
08/07/2003WO2003064678A2 Apparatus for synthesis of radiolabeled compounds
08/06/2003EP1332138A1 Radiopharmaceuticals for diagnosing alzheimer's disease
07/2003
07/31/2003WO2001034566A3 Protease inhibitors
07/31/2003US20030144322 Analogs of cocaine
07/29/2003CA2134092C Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies
07/17/2003US20030135063 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor
07/09/2003EP1325917A1 Radiolabelled alkylamino-benzothiazole and -benzoxazole derivatives and their use as D4 ligands
07/03/2003WO2003053910A1 Stable isotope-labeled amino acid, method of integrating the same into target protein, method of nmr structural analysis of protein and process for producing site-selective stable isotope-labeled fumaric acid and tartaric acid
07/03/2003US20030124059 Imaging agents, precursors thereof and methods of manufacture
07/01/2003US6585953 Fluorinating a 17F-labeled F2 with an alkane, a substituted or unsubstituted alkene, or a substituted or unsubstituted alkyne in the presence of a metal oxide, especially silver oxide, catalyst
06/2003
06/05/2003US20030103896 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents
06/04/2003EP1315689A1 Synthesis of 17f labeled fluoroalkanes
06/03/2003US6574495 Para-hydrogen labelled agents and their use in magnetic resonance imaging
05/2003
05/30/2003WO2002088100A3 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
05/30/2003WO2002070020A3 Polymer precursors of radiolabeled compounds, and methods of making and using the same
05/21/2003EP0765166B1 Radiolabeled annexin-galactose conjugates
05/20/2003US6565828 Bifunctional chelant for attaching diagnostic metals and therpeutic isotopes to target specific biomolecules; heavy metal detoxification
05/06/2003CA2109208C Radiolabeled metal-binding protein for the treatment of arthritis
05/02/2003EP1173184A4 Rho-boronophenylalanine complexes with fructose and related carbohydrates and polyols
04/2003
04/24/2003WO2003002489A3 Solid-phase electrophilic fluorination
04/16/2003EP1301463A1 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
04/15/2003US6548042 Bis-phosphonate compounds
03/2003
03/27/2003WO2003024940A1 Bifunctional chelating agent for actinium
03/19/2003EP1023264B1 New marker, production process and use thereof
03/18/2003US6534488 32P or 33P-labelled bisphosphonates as radiotherapeutic radiopharmaceuticals. The 32P- or 33P-labelled bisphosphonates, which are chemically identical to the unlabelled agent, are expected to target the lesion site in
03/18/2003US6534038 Ternary ligand complexes useful as radiopharmaceuticals
03/13/2003WO2002102743A3 DEUTERATED N-SUBSTITUTED AND α-SUBSTITUTED DIPHENYLALKOXY ACETIC ACID AMINO ALKYL ESTERS AND MEDICAMENTS CONTAINING THESE COMPOUNDS
03/12/2003CN1401629A Image forming agent, its precursor and preparing process thereof
03/11/2003US6531636 Derivatives of 2-archidonoyl glycerol, stable to hydrolysis; ethers derived from long chain fatty alcohols (archidonyl alcohol) bind to the CB1 and CB2 cannabinoid receptors; in vivo effects similar to anandamide and 2-Ara-Gl
03/11/2003US6531314 Growth hormone secretagogue receptor family
03/06/2003WO2002090298A3 Method for the synthesis of 18f marked compounds which are low in carriers
02/2003
02/26/2003EP1285902A1 Method for labeling with tritium
02/26/2003EP0832068B1 Stable reagents for the preparation of radiopharmaceuticals
02/12/2003EP1282631A1 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents
02/11/2003US6517811 Compounds for cancer imaging and therapy
02/11/2003CA2216851C Radiolabeled peptides for diagnosis and therapy
02/06/2003WO2002030937A3 Labeled resiniferatoxin derivatives for use in vanilloid receptor binding assay
02/04/2003US6515112 For use in diagnosis and therapy
01/2003
01/30/2003WO2003008394A1 Novel chelating agents and conjugates thereof, their synthesis and use as diagnostic and therapeutic agents
01/23/2003WO2001005805A9 Novel c-19-halogen-substituted, 5-substituted, 5-substituted or 6,10 carbocyclically condensed steroids of the androst-9(11)-ene-series, methods for the production and use thereof
01/21/2003US6509001 Calcitonin receptor binding reagents
01/09/2003WO2003002489A2 Solid-phase electrophilic fluorination
01/09/2003WO2003002157A1 Solid-phase nucleophilic fluorination
01/07/2003CA2069154C Polypeptides
01/03/2003WO2003000698A1 β-BENZYLOXYASPARTATE DERIVATIVES WITH AMINO GROUP ON BENZENE RING
01/02/2003EP1268497A1 Ternary ligand complexes useful as radiopharmaceuticals
12/2002
12/27/2002WO2002102743A2 DEUTERATED N-SUBSTITUTED AND α-SUBSTITUTED DIPHENYLALKOXY ACETIC ACID AMINO ALKYL ESTERS AND MEDICAMENTS CONTAINING THESE COMPOUNDS
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 27